# BioFreedom QCA Study in CAD Patients

> **NCT03307213** · NA · UNKNOWN · sponsor: **Biosensors Europe SA** · enrollment: 200 (actual)

## Conditions studied

- Coronary Artery Disease
- Cardiac Death
- Myocardial Infarction

## Interventions

- **DEVICE:** BioFreedom™ CoCr Biolimus A9™ stent
- **DEVICE:** BioFreedom™ SS Biolimus A9™ stent

## Key facts

- **NCT ID:** NCT03307213
- **Lead sponsor:** Biosensors Europe SA
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-06-19
- **Primary completion:** 2019-09-30
- **Final completion:** 2021-03-31
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2019-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03307213

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03307213, "BioFreedom QCA Study in CAD Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03307213. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*